New studies, approvals and data on the aging brain, anesthesia and surgery, sleep, prevention and monitoring. Every brief is short, plain-English and linked to its source.
Updated Nov 5, 2026
Sleep
Deep-sleep brain waves that travel less far are tied to tau and next-day memory
UC Berkeley researchers found that in older adults, deep-sleep slow waves travel shorter distances and move more independently, and this pattern was linked to more tau in the frontal brain and weaker overnight memory. The participants did not have Alzheimer's, and the study shows a link, not cause and effect.
Why it matters
It suggests sleep EEG could one day help show early brain changes before memory problems are noticeable.
EEG headband tool to help screen for delirium launches in US hospitals
Ceribell began commercial rollout of AI software that analyzes EEG from a bedside headband for patterns linked to delirium and alerts clinicians. The company says it is the first FDA-cleared device to aid delirium screening and monitoring, meant to support, not replace, bedside assessment.
Why it matters
Delirium is common in hospitalized and ICU patients and often missed, so objective monitoring tools could help teams spot it sooner.
Lifestyle & Prevention
Aspirin linked to lower dementia rates in one genetic group, with more bleeding
In a reanalysis of the ASPREE aspirin trial, people with a particular genetic profile for platelet count had fewer dementia cases on aspirin (1% vs 3.3% on placebo), but major bleeding roughly doubled. Earlier trials found no overall dementia benefit from aspirin, and the result needs confirmation.
Why it matters
It is a reminder that a large relative benefit in a subgroup is not a reason to start a medicine without talking to a doctor.
Policy & Care
National effort aims to bring brain health and dementia care into primary care
The Alzheimer's Association launched the Brain Health & Quality Care Initiative, a national framework to help health systems build risk reduction, cognitive assessment, diagnosis and referral into routine care, starting with primary care. It plans a recognition program for organizations that put it into practice.
Why it matters
Most people first raise memory concerns with a primary care clinician, so better-equipped practices could mean earlier answers.
Policy & Care
CDC renews $20 million in funding for public health work on dementia risk
The CDC awarded the Alzheimer's Association two five-year cooperative agreements totaling $20 million to continue leading the National Healthy Brain Initiative and a BOLD Center of Excellence on Dementia Risk Reduction. The work supports state, local, Tribal and territorial health departments.
Why it matters
Public health programs shape what dementia prevention and caregiving support look like in local communities.
Lifestyle & Prevention
Starting statins early after a diabetes diagnosis linked to lower dementia risk
A Danish registry study of more than 132,000 adults with type 2 diabetes found that starting a statin within a year of diagnosis was associated with a 15% lower relative risk of dementia over 10 years. The study was observational, and the researchers said it should prompt more research rather than change practice on its own.
Why it matters
It adds to evidence that managing heart and blood-vessel risk factors may also matter for the brain.
Diagnostics & Biomarkers
FDA clears a single-biomarker blood test to help assess Alzheimer's
The FDA cleared Roche's Elecsys pTau217 blood test to help identify Alzheimer's-related amyloid in adults 55 and older with signs or symptoms of cognitive decline, in both primary and specialty care. It is not meant to be used on its own, and it is not cleared to predict future dementia.
Why it matters
Blood tests could make an Alzheimer's evaluation easier to get than spinal taps or PET scans.
Diagnostics & Biomarkers
Blood p-tau217 levels linked to risk of memory problems up to 10 years ahead
In about 2,700 cognitively healthy adults, very high blood p-tau217 levels were associated with an estimated 78% risk of cognitive impairment within 10 years. The researchers stress that the test alone cannot predict an individual's future, and more diverse studies are needed.
Why it matters
It points toward identifying people for prevention trials earlier, though it is not yet a personal crystal ball.
Diagnostics & Biomarkers
With a blood test, family doctors diagnosed Alzheimer's nearly as well as specialists
In interim results from a Swedish real-world study, primary care doctors' diagnostic accuracy rose from 65% to 93% after seeing blood test results, close to specialists. The test detects Alzheimer's specifically, so a negative result does not rule out other causes of memory problems.
Why it matters
Accurate testing in primary care could shorten the long wait many families face for a diagnosis.
Dementia & Alzheimer's
FDA approves at-home injection to start lecanemab treatment
The FDA approved Leqembi Iqlik, an under-the-skin autoinjector form of the anti-amyloid drug lecanemab, as a weekly starting dose for early Alzheimer's. Patients or caregivers can give it at home, and the overall safety profile is described as similar to IV dosing, including the need to monitor for ARIA.
Why it matters
Fewer infusion-center visits could make treatment more manageable for eligible patients and families.
Lifestyle & Prevention
Structured lifestyle program boosted thinking skills in older adults across Latin America
In a two-year trial of 1,065 at-risk older adults in 11 countries, a coached program of exercise, diet, brain training and heart-health monitoring improved overall cognition more than a lighter, self-guided program. Both groups got some lifestyle support, so there was no untreated comparison group.
Why it matters
It supports the idea that combined, supported lifestyle changes can benefit brain health across very different communities.
Policy & Care
Dementia will cost the US an estimated $818 billion in 2026, mostly borne by families
A USC-led analysis estimated the full 2026 cost of dementia at $818 billion, counting medical and long-term care, unpaid family care and lost quality of life. About 5.2 million unpaid caregivers provide an estimated 6.8 billion hours of care a year.
Why it matters
Counting unpaid care and quality of life shows how much of dementia's burden falls outside the health system.
Lifestyle & Prevention
Hearing aids that actually help are linked to lower dementia risk
Pooling data from 61,089 adults with hearing loss in 33 countries, researchers found hearing aid users had a 9% lower risk of probable dementia, and 14% lower when users said the devices helped. People who reported little benefit saw no clear reduction. The study is observational.
Why it matters
Hearing loss is a recognized dementia risk factor, and getting well-fitted help may matter, not just owning a device.
Surgery & Anesthesia
Hospitals with geriatric surgery standards screen nearly all older patients for delirium
Hospitals in the American College of Surgeons Geriatric Surgery Verification program screened 94.3% of older surgical patients for delirium, compared with 52.5% elsewhere. Screened patients at these hospitals had shorter stays, though the study was not designed to show that screening prevents delirium.
Why it matters
Delirium can't be managed if it isn't looked for, so asking how a hospital screens is a reasonable question.
Lifestyle & Prevention
Link between blood pressure and dementia may depend on frailty
In 6,135 older adults followed about nine years, high blood pressure was tied to higher dementia risk in robust people, but among frail or pre-frail people, mildly elevated blood pressure was linked to lower risk. The study shows associations only, and the authors say more research is needed before changing care.
Why it matters
It suggests blood pressure targets for brain health may need to account for a person's overall health and frailty.
Surgery & Anesthesia
Delirium after surgery was the strongest predictor of later cognitive decline
In 560 adults aged 70 and older followed for up to six years after major surgery, postoperative delirium was the strongest predictor of long-term cognitive decline, with effects lasting up to five years. Rehospitalizations were also linked to decline but did not explain delirium's effect.
Why it matters
It reinforces that delirium after surgery is not just a passing event and is worth preventing and tracking.
Surgery & Anesthesia
Subtle EEG differences before surgery seen in older adults who later had delirium
In a multicenter study of 330 older adults having major elective surgery, those who later developed postoperative delirium showed slightly reduced beta-band brain connectivity on EEG beforehand, detectable only with advanced analysis. No lasting EEG changes were seen three months after surgery.
Why it matters
It hints that brain-activity measures might someday help identify who is most vulnerable to delirium, though it is not yet a routine test.
Surgery & Anesthesia
Anesthesiologists' magazine devotes an issue to protecting older patients' brains
The American Society of Anesthesiologists published a special ASA Monitor issue on perioperative cognitive care for older adults. Articles cover preoperative cognitive assessment, delirium screening by surgery type, what patients need to know, and the role of technology.
Why it matters
It signals that brain health is becoming a standard part of planning anesthesia and surgery for older adults.
The weekly signal
Get the weekly brief.
The latest brain health research, explained. One short email a week.
iEducational summaries of published research, each linked to its source. Not medical advice. Always talk to your doctor about your own health.